Pyxis Oncology Inc (PYXS)

1.60 ↑0.00 (0.00%)
As of December 31, 1969, 7:00pm EST.

PYXS Chart

Your browser does not support this chart.

Your browser does not support this chart.

  • 52-Week Range: $1.52 - $6.59
  • Market Capitalization: $99.31M
  • Short Percentage: 12.43%
  • Target Price: $10.00
  • Shares Outstanding: 59.47M
  • Next Earnings: Nov 30
View More Stats

Catalysts

DateCategoryCatalyst
2022-03-30
Earnings

PYXS released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.

Open: $4.80 Close: -14.79% Next Day: -15.83% Next Week: -23.33% View More
0 Comments Share
Help your fellow traders

Company Info

Website: https://www.pyxisoncology.com
Address: 321 Harrison Avenue, Boston, MA, United States, 02118
Sector: N/A
Industry: N/A
Full time employees: 54

Stock Details

  • Current Price: $1.60
  • 52-Week Low: $1.52
  • 52-Week High: $6.59
  • Most Recent Quarter: 2024-09-30
  • Shares Float: 39.08M
  • Shares Outstanding: 59.47M
  • Market Capitalization: $99.31M
  • Next Earnings Date: 0000-00-00

Short Interest

  • Shares Short
    (Today):     0
  • Short Ratio: 0.00
  • Shares Short
    (Last Month):     0
  • Short Interest: 12.43%

The short interest for Pyxis Oncology Inc is at 12.43%, which is around average.

Stock Ownership

Your browser does not support this chart.

Retail: 18.91%
Insiders: 24.54%
Instutitions: 56.55%

Analyst Target Price

10.00

Pyxis Oncology Inc is currently $8.40 below Wallstreet Analysts' price target.

Yesterday's Volume

712,764

Interest in Pyxis Oncology Inc has been trending down. The average daily volume in the past 14 days is 1,146,447.

Discussions

Please log in or register to share your thoughts.

iphonepromax10/12/24 09:43pm

$PYXS hang tight
ignore fud and buy dips if you can
everyone be okay????

0 Like Report
TFTSeasonOne6/8/24 07:52pm

$PYXS we have another weekend of the bears calling for a crash
just to wake up Monday to +.5% up.

0 Like Report
breakthisgrip2/22/24 02:10pm

$PYXS one of the poorest performed stocks for a big name.

0 Like Report